Supreme Petrochem Ltd
Supreme Petrochem Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Volume growth target for FY'27-28 is around 10%, assuming ABS plant commissioning by end of current financial year. The company anticipates a growth of around 10% in FY’27 and FY’28, assuming the ABS plant becomes operational by the end of the current financial year. - Of this 10% growth, approximately 3%-4% is expected from the base business, with the remaining 6%-7% coming from ABS operations. - EPS and profits are expected to benefit from the ramp-up of ABS and compounding businesses, which provide more value-added product offerings. - Operating EBITDA margin in Q3 FY’26 stood at 5.47%, with potential improvement expected as ABS operations normalize and demand stabilizes. - The company maintains a debt-free balance sheet and will fund growth CAPEX (~Rs.
From Supreme Petrochem Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Volume growth target for FY'27-28 is around 10%, assuming ABS plant commissioning by end of current financial year.
- Contribution to growth: 3-4% from base business, approximately 7% from ABS operations if started as planned.
- Focus on ABS compounding business anticipated to provide stability and cushion to earnings.
- Polystyrene capacities operated at ~80% utilization; demand pickup expected with styrene price stabilization.
- Strategic CAPEX of Rs. 250-275 crores planned for FY’26 mainly at Chennai, Amdoshi, and Panipat for infrastructure and growth, including EPS Phase 2 starting operations by February/March.
2 more points from Supreme Petrochem Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Supreme Petrochem Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Estimated CAPEX for the coming year (FY’27) is around Rs. 250-275 crores.
- CAPEX will be mainly at three locations: Chennai, Amdoshi, and infrastructure developments at Panipat.
- The EPS Phase 2 expansion is expected to be operational by February-March 2026.
- No new CAPEX or new business announcements apart from Phase 2 ABS and Haryana projects as of now.
- ABS plant commissioning delayed due to equipment malfunction; once operational, focus will be on ramping up production and compounding.
2 more points from Supreme Petrochem Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Supreme Petrochem Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Supreme Petrochem has not taken any advance order book for the ABS plant as they want customers to use the product first for application testing.
- Due to the white color of their ABS material, master batch matching issues caused some delays in sampling and supply.
- Orders from major OEMs for ABS compounds have started coming in after successful sample matching.
- Transition period is ongoing; increased utilization in compounding lines expected once ABS plant restarts.
2 more points from Supreme Petrochem Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Supreme Petrochem Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.6K Cr, net profit ₹168 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Supreme Petrochem Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neochem Bio (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chemicals Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
- Jubilant Agri & Consumer Products Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations: INR 4,510 million, up 13% YoY from INR 3,975 million in Q3 FY25 (Page 20). Key investor presentation takeaways from Jubilant Ag
Arthneeti Pro · Annual
Supreme Petrochem Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Supreme Petrochem Ltd Q3 FY26 results?
Volume growth target for FY'27-28 is around 10%, assuming ABS plant commissioning by end of current financial year. The company anticipates a growth of around 10% in FY’27 and FY’28, assuming the ABS plant becomes operational by the end of the current financial year. - Of this 10% growth, approximately 3%-4% is expected from the base business, with the remaining 6%-7% coming from ABS operations. - EPS and profits are expected to benefit from the ramp-up of ABS and compounding businesses, which provide more value-added product offerings. - Operating EBITDA margin in Q3 FY’26 stood at 5.47%, with potential improvement expected as ABS operations normalize and demand stabilizes. - The company maintains a debt-free balance sheet and will fund growth CAPEX (~Rs.
What is Supreme Petrochem Ltd share price analysis?
Supreme Petrochem Ltd currently shows a neutral. The stock trades at a P/E of 27.1 with a market cap of ₹13,276 Cr. Investors should review the full earnings analysis for detailed insights.
Is Supreme Petrochem Ltd planning capital expenditure?
Estimated CAPEX for the coming year (FY’27) is around Rs.
Keep Supreme Petrochem Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.